What is the recommended treatment for a female patient with dysuria, recurrent Urinary Tract Infections (UTIs), and no fever (afebrile)?

Treatment of Recurrent UTIs in Female Patients with Dysuria

For a female patient with dysuria and recurrent UTIs who is afebrile, first-line treatment should include nitrofurantoin, trimethoprim-sulfamethoxazole, or fosfomycin based on local antibiogram patterns, with treatment duration generally not exceeding 7 days. 1

Diagnosis Confirmation

• Obtain urine culture and sensitivity testing before initiating treatment to confirm diagnosis and guide antibiotic selection 1, 2
• Document positive urine cultures associated with prior symptomatic episodes to establish the diagnosis of recurrent UTI (defined as ≥3 UTIs/year or ≥2 UTIs in 6 months) 1, 3
• Consider obtaining repeat urine studies if initial specimen is suspect for contamination 1

Acute Treatment Options

• First-line antibiotics for acute episodes:
  • Nitrofurantoin 50-100 mg QID or 100 mg BID for 5 days 1, 2, 4
  • Trimethoprim-sulfamethoxazole 160/800 mg BID for 3 days 1, 5, 4
  • Fosfomycin trometamol 3 g single dose 2, 4
• Use shortest effective duration of antibiotics, generally no longer than 7 days 1, 4
• Consider patient-initiated treatment (self-start) for select patients while awaiting urine culture results 1, 2

Prevention Strategies

Non-antimicrobial Options

• Behavioral modifications: maintain adequate hydration, void after intercourse, avoid prolonged holding of urine 3
• For postmenopausal women: consider vaginal estrogen with or without lactobacillus-containing probiotics 3, 2
• Consider methenamine hippurate as a non-antibiotic alternative 3, 2

Antimicrobial Prophylaxis Options

• For premenopausal women with post-coital infections: low-dose antibiotic within 2 hours of sexual activity 3
• For recurrent infections unrelated to sexual activity: continuous daily antibiotic prophylaxis for 6-12 months 3, 6
• Prophylactic options include:
  • Nitrofurantoin 50 mg daily
  • Trimethoprim-sulfamethoxazole 40/200 mg daily
  • Trimethoprim 100 mg daily 3, 7

Important Considerations

• Do not perform surveillance urine testing or treat asymptomatic bacteriuria in patients with rUTI 1, 2
• Antibiotic choice should take into account:
  • Patient's prior organism identification and susceptibility profile
  • Drug allergies
  • Antibiotic stewardship principles 3, 8
• Avoid broad-spectrum antibiotics like fluoroquinolones and cephalosporins when narrower options are available 3, 9
• Consider rotating antibiotics at 3-month intervals to avoid selection of antimicrobial resistance 3

Common Pitfalls to Avoid

• Treating asymptomatic bacteriuria, which fosters antimicrobial resistance 1, 2
• Using antibiotics beyond recommended duration 1, 4
• Failing to obtain urine culture before initiating treatment in recurrent cases 1
• Not considering non-antimicrobial options before antimicrobial prophylaxis 3
• Using fluoroquinolones for empiric treatment due to increased rates of resistance 8, 9